Cargando…
A three-protein signature and clinical outcome in esophageal squamous cell carcinoma
Current staging is inadequate to precisely predict clinical outcome of esophageal squamous cell carcinoma (ESCC) and determine treatment choices, which vary from operation alone to intensive multimodal regimens. The purpose of this study is to investigate the prognostic values of an immunohistochemi...
Autores principales: | Cao, Hui-Hui, Zhang, Shi-Yi, Shen, Jin-Hui, Wu, Zhi-Yong, Wu, Jian-Yi, Wang, Shao-Hong, Li, En-Min, Xu, Li-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467159/ https://www.ncbi.nlm.nih.gov/pubmed/25605255 |
Ejemplares similares
-
A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015) -
A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma
por: Huang, Guo-Wei, et al.
Publicado: (2018) -
A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis
por: Cao, Hui-Hui, et al.
Publicado: (2014) -
Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014) -
A three‐gene signature from protein–protein interaction network of LOXL2‐ and actin‐related proteins for esophageal squamous cell carcinoma prognosis
por: Zhan, Xiu‐hui, et al.
Publicado: (2017)